The analysis of carnitines is indicated in patients who fail to thrive, hypotonia, chronic muscle weakness, cardiomyopathy, intermittent episodes of weakness and encephalopathy, renal Fanconi's syndrome, hypoglycemic episodes, metabolic acidosis, or hypo ketotic dicarboxylic acidurias.

This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the Food and Drug Administration.